Investors

Vox Biomedical, with support from the Department of Transportation, is developing a field sobriety marijuana breath analyzer using laser-based technology. The company is projecting sales of nearly $50 Million within 5 years in a market that is likely to grow to over $1 Billion within a decade. We are seeking investments to help accelerate development of the device, create a workable prototype, and initiate marketing efforts.

About Us

  • Vox Biomedical has focused on development of optoelectronics-based medical instruments for drug detection.

The Solution

  • The Vox marijuana breath analyzer uses laser spectroscopy to measure THC in exhaled breath, which are then correlated with degree of intoxication.
  • This approach provides improved sensitivity and can distinguish THC from CBD and other compounds to avoid false positives.
  • It can also be used at the scene of a traffic stop just like a common alcohol breathalyzer.

 

The Product

The Vox marijuana breath analyzer can be used at the scene of a traffic stop, like existing alcohol breathalyzers. The subject breathes into a disposable cartridge, from which a filter is removed and analyzed on-site. The filter is then archived for future legal proceedings.

Business Model

Revenue will be generated from 2 sources:

  • Sale of breath analyzer units.
  • Accessory materials, which include disposable cartridges and achievable filters.
    • Initial target market will be law enforcement agencies.
    • An even larger potential market exists for employee drug screening.

Market Opportunity

  • Police and law enforcement market in the U.S.
  • Workplace detection market
  • The marijuana breath analyzer market should be comparable to alcohol breathalyzer market.

Strategy

Vox Biomedical’s initial development efforts are being funded by DOT’s National Highway Traffic Safety Administration. Based on preliminary positive Phase I results, DOT has expressed enthusiasm for the technology and recently awarded a Phase II program for additional development and prototyping of the instrument. DOT endorsement of the technology will be critical to achieving market acceptance, and will significantly accelerate market penetration.

Sales Projections by 2025

  • $1.5 Billion Total Addressable Market
  • Assuming 50% Market Adoption Rate ($750 Million)
  • 20% Market Share ($150 Million)

Vox Advantages

  • Ease of use and portable for roadside
  • Detect and differentiate between THC & CBD
  • Higher sensitivity
  • No false positives
  • Lower cost
  • Archivable for trial access
  • Usable at point-of-stop with no warrant required
  • Longer time of detection for THC